Related Experiment Video
Updated: Jun 18, 2026
13:44
Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
Published on: December 9, 2022
Pharmaceuticals from development to practice: learnings from an online curriculum.
David W Price1, Marsha A Raebel, Douglas A Conner
1Kaiser Permanente Institute for Health Research, 10065 E Harvard Ave, Ste 300, Denver, CO 80231, USA. david.price@kp.org
The American Journal of Managed Care
|December 4, 2009
Summary
A pilot online curriculum improved clinician knowledge and intent to change practice regarding off-label prescribing and direct-to-consumer advertising. Further research is needed to confirm effects on prescribing patterns.
Area of Science:
- Medical Education
- Pharmaceutical Marketing
- Clinical Practice
Background:
- Clinicians require education on navigating complex pharmaceutical information.
- Direct-to-consumer advertising influences patient inquiries and prescribing decisions.
- Off-label prescribing necessitates careful consideration of evidence and patient safety.
Purpose of the Study:
- To evaluate a pilot online curriculum for clinicians.
- To assess education on off-label prescribing and unbiased drug information.
- To improve responses to patient inquiries about advertised medications.
Main Methods:
- A case-oriented online curriculum with reflective questions and faculty interaction was developed.
- Pilot testing involved 52 clinicians over four months.
- Outcomes included self-reported knowledge, intent-to-change practice, and prescribing patterns.
Main Results:
- Most participants reported increased knowledge and intent to change practice.
- Several clinicians reported actual practice changes post-curriculum.
- No significant difference in prescribing patterns was observed between intervention and control groups.
Conclusions:
- Targeted curricula can enhance clinician knowledge and practice intentions.
- Subjective changes in knowledge and practice intent were observed.
- Larger studies are required to validate the impact on prescribing patterns.
Related Concept Videos
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...